Citation Impact
Citing Papers
Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia
2013
Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
2012
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
Pre-eclampsia
2023
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Cardiovascular Abnormalities in Patients with Major Depressive Disorder
2009
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk
2007
The effects of oxidative stress on female reproduction: a review
2012 Standout
Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation
2013
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
The Two Stage Model of Preeclampsia: Variations on the Theme
2008
The paradox of low BNP levels in obesity
2011
Heart rate variability analysis using a ballistocardiogram during Valsalva manoeuvre and post exercise
2011
Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation
2009
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
2011
A possible protective role of Nrf2 in preeclampsia
2014
Advances in metal-induced oxidative stress and human disease
2011 Standout
New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity
2010
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
2009
Interactions between Angiotensin ll and Atrial Natriuretic Peptide in Renomedullary Interstitial Cells: The Role of Neutral Endopeptidase
2006
Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis
2012
Enhanced platelet activation by prolactin in patients with ischemic stroke
2006
Hyperprolactinemia in Patients on Antipsychotic Drugs Causes ADP-Stimulated Platelet Activation That Might Explain the Increased Risk for Venous Thromboembolism: Pilot Study
2003
Effects of prolactin on platelet activation and blood clotting
2013 StandoutNobel
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
The Global Epidemic of the Metabolic Syndrome
2018 Standout
A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia
2019
Prolactin Receptor Signaling during Platelet Activation
2003
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
2008
Adipose tissue and fetal programming
2012
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Prediction and Prevention of Recurrent Preeclampsia
2008
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Relationship between Polycystic Ovarian Syndrome and Subsequent Gestational Diabetes Mellitus: A Nationwide Population-Based Study
2015
Physiological changes in pregnancy
2016 Standout
Insulin sensitivity in late gestation and early postpartum period: the role of circulating maternal adipokines
2011
Resolution of Hypertension and Proteinuria After Preeclampsia
2009
Haemolytic uraemic syndrome
2017
Pre-eclampsia
2010 Standout
Pre-eclampsia
2021
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
2009
Molecular and Vascular Targets in the Pathogenesis and Management of the Hypertension Associated with Preeclampsia
2010
What We Talk About When We Talk About Fat
2014 Standout
RNAi modulation of placental sFLT1 for the treatment of preeclampsia
2018
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
Macroprolactinemia, like hyperprolactinemia, may promote platelet activation
2010
FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
2014
A Loss-of-Function Mutation in Natriuretic Peptide Receptor 2 (Npr2) Gene Is Responsible for Disproportionate Dwarfism in cn/cn Mouse
2005
Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies
2019
Evaluation of High-Sensitivity C-Reactive Protein and Serum Lipid Profile in Southeastern Nigerian Women with Pre-Eclampsia
2015 Standout
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
2014
Placental Growth Factor and Soluble FMS-Like Tyrosine Kinase-1 in Early-Onset and Late-Onset Preeclampsia
2007
Polycystic ovary syndrome
2016 Standout
Natriuretic Peptides: Their Structures, Receptors, Physiologic Functions and Therapeutic Applications
2008
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Irisin as a muscle-derived hormone stimulating thermogenesis – A critical update
2014
Adipose Tissue as an Endocrine Organ
2004 Standout
Pre-eclampsia
2015 Standout
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
2006
Postpartum physiology, psychology and paediatric follow up study (P4 Study) – Study protocol
2016
MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
2012
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Prolactin does not affect human platelet aggregation or secretion
2009
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models
2008
Involvement of the Heme Oxygenase System in the Development of Preeclampsia and as a Possible Therapeutic Target
2014
Ballistocardiography and Seismocardiography: A Review of Recent Advances
2014 Standout
VEGF-VEGFR Signals in Health and Disease
2014
2015
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy
2012
Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters
2010
First-Trimester Prediction of Hypertensive Disorders in Pregnancy
2009
Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine
2008
Redefining Preeclampsia Using Placenta-Derived Biomarkers
2013
Tracking placental development in health and disease
2020
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
2017
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Is inflammation the cause of pre-eclampsia?
2011
Hypertensive Disorders of Pregnancy
2018 Standout
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
N-Terminal Pro-B-Type Natriuretic Peptide Concentrations Are Markedly Higher in the Umbilical Cord Blood of Newborns than in Their Mothers
2005
Preterm labor: One syndrome, many causes
2014 StandoutScience
Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia
2012 StandoutNobel
Reviewing Peripartum Cardiomyopathy: Current State of Knowledge
2009
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
2008
Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes
2016
Leptin and Cardiovascular Disease
2008
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia
2013
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Holger Stepan being referenced
Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion
2007
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
2011
Cells on a Chip - the Use of Electric Properties for Highly Sensitive Monitoring of Blood-Derived Factors Involved in Angiotensin II Type 1 Receptor Signalling
2005
Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion
2008
Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function
2007
Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide
2004
Proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension postpartum
2005
Fibrosis rather than blood pressure determines cardiac BNP expression in mice
2003
Differences in Platelet Activation by Prolactin and Leptin
2004
Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function
2008
Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia
2009
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia
2015
Relation of ANP and BNP to their N‐terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus
2004
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia
2011
Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery
2013
Die peripartale Kardiomyopathie?der (un)bekannte geburtshilflich-kardiologische Notfall
2003
Secretory products from human adipocytes impair endothelial function via nuclear factor κB
2007
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
2016
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
2009
Longitudinal Analysis of Heart Rate Variability in Chronic Hypertensive Pregnancy
2005
Serum Levels of Angiopoietin-Related Growth Factor Are Increased in Preeclampsia
2008
Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders
2007
Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice
2000
Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells
2009
Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?
2006
PRL as a Novel Potent Cofactor for Platelet Aggregation
2001
New Insights into the Biology of Preeclampsia
2006
Cardiomyocyte‐restricted over‐expression of C‐type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice
2007
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
2011
Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth Restriction
2007
Relation between Circulating Angiotensin II Type 1 Receptor Agonistic Autoantibodies and Soluble fms-Like Tyrosine Kinase 1 in the Pathogenesis of Preeclampsia
2006
New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia
2013
The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia
2012
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
2011
Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature
2005
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
2013